Robert M Wenham Selected Research

Breast Neoplasms (Breast Cancer)

1/2019	Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.
4/2015	BAD-mediated apoptotic pathway is associated with human cancer development.
12/2004	Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert M Wenham Research Topics

Disease

59	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 08/2002
46	Neoplasms (Cancer) 05/2024 - 01/2008
11	Ovarian Epithelial Carcinoma 12/2023 - 12/2004
8	Endometrial Neoplasms (Endometrial Cancer) 11/2023 - 01/2009
5	Carcinoma (Carcinomatosis) 01/2022 - 06/2013
4	Disease Progression 01/2023 - 10/2014
3	Fallopian Tube Neoplasms 10/2022 - 08/2014
3	Anemia 08/2021 - 10/2014
3	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2004
3	Prostatic Neoplasms (Prostate Cancer) 08/2013 - 02/2005
2	Inflammation (Inflammations) 07/2023 - 06/2023
2	Fatigue 06/2023 - 07/2013
2	Vascular System Injuries 08/2021 - 07/2009
2	Vomiting 01/2020 - 01/2017
2	Infections 01/2019 - 10/2002
2	Neutropenia 01/2019 - 10/2014
2	Endometriosis 10/2018 - 12/2004
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Cholangiocarcinoma 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Wounds and Injuries (Trauma) 08/2021
1	Venous Thromboembolism 08/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2020
1	Diarrhea 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Vulvar Neoplasms (Vulvar Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

16	PlatinumIBA 05/2024 - 07/2013
12	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 10/2012
10	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 10/2012
6	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2020
6	Cisplatin (Platino)FDA LinkGeneric 02/2016 - 01/2008
4	Bevacizumab (Avastin)FDA Link 10/2022 - 07/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
4	niraparibIBA 12/2019 - 08/2013
4	trebananibIBA 01/2019 - 10/2014
4	MicroRNAs (MicroRNA)IBA 10/2016 - 01/2008
3	AntigensIBA 01/2023 - 01/2021
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016 - 01/2012
2	PafolacianineIBA 10/2023 - 10/2019
2	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
2	Gemcitabine FDA Link 01/2020 - 07/2012
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2019 - 08/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 01/2017
2	Progestins (Progestagens)IBA 01/2019 - 12/2013
2	1-dodecylpyridoxal (PLD)IBA 01/2017 - 10/2014
2	liposomal doxorubicin (Doxil)FDA Link 01/2017 - 10/2014
2	Sorafenib (BAY 43-9006)FDA Link 08/2014 - 01/2009
2	Docetaxel (Taxotere)FDA Link 03/2014 - 07/2013
2	Insulin (Novolin)FDA Link 07/2007 - 02/2005
2	CytosineIBA 07/2007 - 02/2005
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2004 - 03/2003
1	cediranib (AZD2171)IBA 05/2024
1	TabletsIBA 05/2024
1	olaparibIBA 05/2024
1	sapanisertibIBA 11/2023
1	serabelisibIBA 11/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2023
1	Type II Tumor Necrosis Factor ReceptorsIBA 06/2023
1	Type I Tumor Necrosis Factor ReceptorsIBA 06/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023
1	Folic Acid AntagonistsIBA 01/2023
1	Viral DNAIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	CreatinineIBA 01/2023
1	farletuzumabIBA 01/2023
1	delta proteinIBA 10/2022
1	navicixizumabIBA 10/2022
1	Odorant Receptors (Odorant Receptor)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Caveolin 1IBA 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	polymeric IgAIBA 01/2021
1	adavosertibIBA 01/2020
1	ralimetinibIBA 01/2020
1	Platelet Factor 3 (PF 3)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020

Therapy/Procedure

20	Therapeutics 04/2024 - 01/2009
19	Drug Therapy (Chemotherapy) 12/2023 - 10/2011
4	Salpingo-oophorectomy 01/2020 - 01/2017
3	Cytoreduction Surgical Procedures 10/2023 - 07/2015
3	Immunotherapy 01/2022 - 01/2017
3	Lymph Node Excision (Lymph Node Dissection) 08/2021 - 07/2009
3	Radiotherapy 10/2020 - 01/2020
2	Palliative Care (Palliative Therapy) 06/2023 - 01/2017
2	Chemoradiotherapy 10/2020 - 01/2020
2	Adjuvant Chemotherapy 01/2019 - 10/2018
2	Pelvic Exenteration 10/2018 - 11/2009
2	Chemoprevention 02/2009 - 01/2009
1	Blood Transfusion (Blood Transfusions) 08/2021
1	Sutures (Suture) 08/2021
1	Brachytherapy 10/2020
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020